However, available data has demonstrated that GLP-1-prompted weight loss is correlated with an improvement in menstrual regularity and pregnancy rate in participants with PCOS
Darvish-Ghane, S., Quintana, C., Beaulieu, J
These data indicated that the status of cell in pancreas and intestine is maintained and the molecular expression level of cell dysfunction is increased after treatment
The STEP clinical trial program reported that approximately 74% of participants on semaglutide 2.4mg experienced at least one gastrointestinal adverse event
On its official website, Refills advertises outcomes and access metrics such as "92% of patients report improved energy," "3x faster weight loss compared to lifestyle changes alone," nationwide access, and more than 10,000 personalized plans
Vendors operating through social media DMs, temporary websites, or anonymous email addresses create accountability gaps that make recourse impossible if something goes wrong